BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cardinale V, Carpino G, Reid L, Gaudio E, Alvaro D. Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World J Gastrointest Oncol 2012; 4(5): 94-102 [PMID: 22645632 DOI: 10.4251/wjgo.v4.i5.94]
URL: https://www.wjgnet.com/1948-5204/full/v4/i5/94.htm
Number Citing Articles
1
Vincenzo Cardinale, Anastasia Renzi, Guido Carpino, Alessia Torrice, Maria C. Bragazzi, Felice Giuliante, Agostino M. De Rose, Alice Fraveto, Paolo Onori, Chiara Napoletano, Antonio Franchitto, Alfredo Cantafora, GianLuca Grazi, Nicola Caporaso, Giuseppe D'Argenio, Gianfranco Alpini, Lola M. Reid, Eugenio Gaudio, Domenico Alvaro. Profiles of Cancer Stem Cell Subpopulations in CholangiocarcinomasThe American Journal of Pathology 2015; 185(6): 1724 doi: 10.1016/j.ajpath.2015.02.010
2
Szilvia Lilla Csoma, Judit Bedekovics, Gergő Veres, Anita Árokszállási, Csilla András, Gábor Méhes, Attila Mokánszki. Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation SequencingCancers 2022; 14(1): 233 doi: 10.3390/cancers14010233
3
Ijin Joo. Recent Updates in the Imaging Diagnosis of CholangiocarcinomaJournal of the Korean Society of Radiology 2019; 80(3): 394 doi: 10.3348/jksr.2019.80.3.394
4
Pier Francesco Ferrucci, Emilia Cocorocchio, Guido Bonomo, Gianluca Maria Varano, Paolo Della Vigna, Franco Orsi. A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery SystemCells 2021; 10(1): 70 doi: 10.3390/cells10010070
5
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 605 doi: 10.1007/978-3-319-26956-6_31
6
Pedro M. Rodrigues, Paula Olaizola, Nuno A. Paiva, Irene Olaizola, Alona Agirre-Lizaso, Ana Landa, Luis Bujanda, Maria J. Perugorria, Jesus M. Banales. Pathogenesis of CholangiocarcinomaAnnual Review of Pathology: Mechanisms of Disease 2021; 16(1): 433 doi: 10.1146/annurev-pathol-030220-020455
7
Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reportsBMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-520
8
Xiaobo Cai, Jun Li, Xiaodong Yuan, Jingbo Xiao, Steven Dooley, Xinjian Wan, Honglei Weng, Lungen Lu. CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinomaJournal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1423-9
9
Carlie S. Sigel, Esther Drill, Yi Zhou, Olca Basturk, Gokce Askan, Linda M. Pak, Efsevia Vakiani, Tao Wang, Thomas Boerner, Richard K.G. Do, Amber L. Simpson, William Jarnagin, David S. Klimstra. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct PatternsAmerican Journal of Surgical Pathology 2018; 42(10): 1334 doi: 10.1097/PAS.0000000000001118
10
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, Réka Dóra, Endre Kontsek, Alíz Gógl, András Kiss, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, Katalin Borka. Cholangiocarcinoma: Classification, Histopathology and Molecular CarcinogenesisPathology & Oncology Research 2020; 26(1): 3 doi: 10.1007/s12253-018-0491-8
11
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
12
Francesca Vita, Irene Olaizola, Francesco Amato, Colin Rae, Sergi Marco, Jesus M. Banales, Chiara Braconi. Heterogeneity of Cholangiocarcinoma Immune BiologyCells 2023; 12(6): 846 doi: 10.3390/cells12060846
13
Steffen Zender, Irina Nickeleit, Torsten Wuestefeld, Inga Sörensen, Daniel Dauch, Przemyslaw Bozko, Mona El-Khatib, Robert Geffers, Hueseyin Bektas, Michael P. Manns, Achim Gossler, Ludwig Wilkens, Ruben Plentz, Lars Zender, Nisar P. Malek. A Critical Role for Notch Signaling in the Formation of Cholangiocellular CarcinomasCancer Cell 2013; 23(6): 784 doi: 10.1016/j.ccr.2013.04.019
14
Ju Gang Nam, Jeong Min Lee, Ijin Joo, Su Joa Ahn, Jin Young Park, Kyoung Bun Lee, Joon Koo Han. Intrahepatic Mass-Forming Cholangiocarcinoma: Relationship Between Computed Tomography Characteristics and Histological SubtypesJournal of Computer Assisted Tomography 2018; 42(3): 340 doi: 10.1097/RCT.0000000000000695
15
Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing LinkCells 2019; 8(10): 1172 doi: 10.3390/cells8101172
16
Hung-Chune Maa, Pham van Tuyen, Yen-Lin Chen, Yao-Nan Yuan. MCRS1 EXPRESSION MORE IN TUMOR PART AND SERVES AS A POOR PROGNOSTIC FACTOR IN EXTRAHEPATIC CHOLANGIOCARCINOMAGLOBAL JOURNAL FOR RESEARCH ANALYSIS 2021; : 72 doi: 10.36106/gjra/7809476
17
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and ChallengesRadiology 2018; 288(1): 7 doi: 10.1148/radiol.2018171187
18
Winnie A. Mar, Hing Kiu Chan, Surbhi B. Trivedi, Senta M. Berggruen. Imaging of Intrahepatic CholangiocarcinomaSeminars in Ultrasound, CT and MRI 2021; 42(4): 366 doi: 10.1053/j.sult.2021.04.001
19
Jesper B. Andersen. Molecular pathogenesis of intrahepatic cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 101 doi: 10.1002/jhbp.155
20
Hector Perez-Montoyo. Therapeutic Potential of Autophagy Modulation in CholangiocarcinomaCells 2020; 9(3): 614 doi: 10.3390/cells9030614
21
Saumya Jayakumar, Mary Lee Krinsky. Encyclopedia of Gastroenterology2020; : 470 doi: 10.1016/B978-0-12-801238-3.65865-8
22
Giulia Anichini, Laura Carrassa, Barbara Stecca, Fabio Marra, Chiara Raggi. The Role of the Hedgehog Pathway in CholangiocarcinomaCancers 2021; 13(19): 4774 doi: 10.3390/cancers13194774
23
Vincenzo Cardinale, Maria Consiglia Bragazzi, Guido Carpino, Alessia Torrice, Yunfang Wang, Lola McAdams Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinomas: New Insights from the Discovery of Stem Cell Niches in Peribiliary Glands of the Biliary TreeAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/794953
24
Tsunekazu Oikawa. Cancer Stem cells and their cellular origins in primary liver and biliary tract cancersHepatology 2016; 64(2): 645 doi: 10.1002/hep.28485
25
Antonio Cigliano, Xin Chen, Diego F. Calvisi. Current challenges to underpinning the genetic basis for cholangiocarcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(5): 511 doi: 10.1080/17474124.2021.1915128
26
Wencheng Zhang, Yangyang Cui, Yuan Du, Yong Yang, Ting Fang, Fengfeng Lu, Weixia Kong, Canjun Xiao, Jun Shi, Lola M. Reid, Zhiying He. Liver cell therapies: cellular sources and grafting strategiesFrontiers of Medicine 2023; 17(3): 432 doi: 10.1007/s11684-023-1002-1
27
Rosa B. Schmuck, Cynthia V. de Carvalho‐Fischer, Christopher Neumann, Johann Pratschke, Marcus Bahra. Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entityCancer Medicine 2016; 5(1): 88 doi: 10.1002/cam4.566
28
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, Eric Aksu, Kevin Lopez, Yujin Park, Arthur Cross-Najafi, Ping Li, Debjyoti Kundu, Michael G. House, Sanjukta Chakraborty, Shannon Glaser, Lindsey Kennedy, Heather Francis, Wenjun Zhang, Gianfranco Alpini, Burcin Ekser. Development and Characterization of Human Primary Cholangiocarcinoma Cell LinesThe American Journal of Pathology 2022; 192(9): 1200 doi: 10.1016/j.ajpath.2022.05.007
29
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
30
Sumera I. Ilyas, Gregory J. Gores. Pathogenesis, Diagnosis, and Management of CholangiocarcinomaGastroenterology 2013; 145(6): 1215 doi: 10.1053/j.gastro.2013.10.013
31
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinomaCancer Letters 2016; 379(2): 253 doi: 10.1016/j.canlet.2016.02.038
32
Sukanya Roy, Shannon Glaser, Sanjukta Chakraborty. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic MechanismsFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00293
33
Mingyu Yang, Meng Li, Zhuozhen Lyu, Zhen Yang. Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?Cancer Management and Research 2023; : 335 doi: 10.2147/CMAR.S406150
34
Kyoungbun Lee, Young Seok Song, Yoonju Shin, Xianyu Wen, Younghoon Kim, Nam-Yun Cho, Jeong Mo Bae, Gyeong Hoon Kang. Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological featuresScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72810-0
35
Maria Zulfiqar, Deyali Chatterjee, Norihide Yoneda, Mark J. Hoegger, Maxime Ronot, Elizabeth M. Hecht, Nina Bastati, Ahmed Ba-Ssalamah, Mustafa R. Bashir, Kathryn Fowler. Imaging Features of Premalignant Biliary Lesions and Predisposing Conditions with Pathologic CorrelationRadioGraphics 2022; 42(5): 1320 doi: 10.1148/rg.210194
36
Zhiliang Wu, Thidarut Boonmars, Isao Nagano, Sirintip Boonjaraspinyo, Piyarat Srinontong, Panaratana Ratasuwan, Khuntikeo Narong, Phuangphaka Sadee Nielsen, Yoichi Maekawa. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis‐associated cholangiocarcinomaInternational Journal of Cancer 2016; 138(2): 396 doi: 10.1002/ijc.29721
37
Sravanthi Mantripragada, Ashish Chawla. Cholangiocarcinoma: Part 1, Pathological and Morphological Subtypes, Spectrum of Imaging Appearances, Prognostic Factors and StagingCurrent Problems in Diagnostic Radiology 2022; 51(3): 351 doi: 10.1067/j.cpradiol.2021.03.008
38
Ijin Joo, Haeryoung Kim, Jeong Min Lee. Cancer Stem Cells in Primary Liver Cancers: Pathological Concepts and Imaging FindingsKorean Journal of Radiology 2015; 16(1): 50 doi: 10.3348/kjr.2015.16.1.50
39
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews Gastroenterology & Hepatology 2020; 17(9): 557 doi: 10.1038/s41575-020-0310-z
40
Iris E.M. de Jong, Otto B. van Leeuwen, Ton Lisman, Annette S.H. Gouw, Robert J. Porte. Repopulating the biliary tree from the peribiliary glandsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1524 doi: 10.1016/j.bbadis.2017.07.037
41
Yasuni Nakanuma, Takashi Miyata, Tsuneyuki Uchida. Latest advances in the pathological understanding of cholangiocarcinomasExpert Review of Gastroenterology & Hepatology 2016; 10(1): 113 doi: 10.1586/17474124.2016.1104246
42
Zhenyang Shen, Jingbo Xiao, Junjun Wang, Lungen Lu, Xinjian Wan, Xiaobo Cai. Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinomaBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01471-0
43
Sai Sandeep Annamaraju, Sai Charitha Mullaguri, Ravikanth Vishnubhotla, Rama Krishna Kancha. Biomedical Aspects of Solid Cancers2024; : 85 doi: 10.1007/978-981-97-1802-3_8
44
Larissa Muething, James R. Burton. Primary Sclerosing Cholangitis2017; : 13 doi: 10.1007/978-3-319-40908-5_2
45
Alphonse E. Sirica, Roberto J. Groszmann, Yasuko Iwakiri, Tamar H. Taddei. Notching up on the cellular origins of intrahepatic cholangiocarcinomaHepatology 2013; 57(4): 1668 doi: 10.1002/hep.26313
46
A. Sabaté-Llobera, L. Gràcia-Sánchez, G. Reynés-Llompart, E. Ramos, L. Lladó, J. Robles, T. Serrano, J. Mestres-Martí, C. Gámez-Cenzano. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markersClinical and Translational Oncology 2019; 21(3): 324 doi: 10.1007/s12094-018-1926-0
47
Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo, Karen Zhang, Apurva Jain, Anaemy Danner De Armas, Stephanie Reyes, Tri Minh Le, Osama E Rahma, Jennifer Stanton, Thomas T DeLeon, Marc Roth, Mary Linton B Peters, Andrew X Zhu, Jochen K Lennerz, A John Iafrate, Kylie Boyhen, Christine VanCott, Lewis R Roberts, Stacie Lindsey, Nora Horick, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Robin Kate Kelley, Milind M Javle, Lipika Goyal. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinomaJNCI: Journal of the National Cancer Institute 2023; 115(7): 870 doi: 10.1093/jnci/djad046
48
Myeong-Jin Kim, Hyungjin Rhee, Ha Young Woo. A dichotomous imaging classification for cholangiocarcinomas based on new histologic conceptsEuropean Journal of Radiology 2019; 113: 182 doi: 10.1016/j.ejrad.2019.02.025
49
Mackenzie Owen, Mina S. Makary, Eliza W. Beal. Locoregional Therapy for Intrahepatic CholangiocarcinomaCancers 2023; 15(8): 2384 doi: 10.3390/cancers15082384
50
Richard K. Do, Daniel T. Boll. Diseases of the Abdomen and Pelvis 2023-2026IDKD Springer Series 2023; : 121 doi: 10.1007/978-3-031-27355-1_8
51
Takeshi Makiuchi, Tomotaka Sobue, Tetsuhisa Kitamura, Junko Ishihara, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane. Relationship between Meat/Fish Consumption and Biliary Tract Cancer: The Japan Public Health Center–Based Prospective StudyCancer Epidemiology, Biomarkers & Prevention 2020; 29(1): 95 doi: 10.1158/1055-9965.EPI-19-0514
52
Vincenzo Cardinale, Guido Carpino. Multilevel heterogeneity of biliary tract cancers may affect the modelling of prognosisLiver International 2017; 37(12): 1773 doi: 10.1111/liv.13565
53
Giuseppe Losurdo, Antonietta Gerarda Gravina, Luca Maroni, Enrico Maria Gabrieletto, Gianluca Ianiro, Alberto Ferrarese, Alessia Visintin, Leonardo Frazzoni, Gaia Pellegatta, Anna Sessa, Loris Lopetuso, Serena Porcari. Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspectiveDigestive and Liver Disease 2022; 54(5): 583 doi: 10.1016/j.dld.2021.08.008
54
Daniel H. Ahn, Tanios Bekaii-Saab. Textbook of Gastrointestinal Oncology2019; : 185 doi: 10.1007/978-3-030-18890-0_11
55
Tomoki Yagai, Satoshi Matsui, Kenichi Harada, Fuyuki F. Inagaki, Eiko Saijou, Yasushi Miura, Yasuni Nakanuma, Atsushi Miyajima, Minoru Tanaka, Matias A Avila. Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary treePLOS ONE 2017; 12(4): e0175355 doi: 10.1371/journal.pone.0175355
56
Joanna Socha, Maciej Michalak, Grzegorz Wołąkiewicz, Lucyna Kepka. Nodal areas of potential geographic error in adjuvant radiotherapy for biliary tract cancerRadiotherapy and Oncology 2017; 125(2): 365 doi: 10.1016/j.radonc.2017.09.025
57
Marcus Bahra, Ali Yahyazadeh. Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)Cancers 2023; 15(3): 774 doi: 10.3390/cancers15030774
58
Chiara Raggi, Pietro Invernizzi, Jesper B. Andersen. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological conceptsJournal of Hepatology 2015; 62(1): 198 doi: 10.1016/j.jhep.2014.09.007
59
Alexander Arnold, Marcus Bahra, Dido Lenze, Maren Bradtmöller, Katrin Guse, Claire Gehlhaar, Hendrik Bläker, Frank L. Heppner, Arend Koch. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assayExperimental and Molecular Pathology 2015; 99(2): 344 doi: 10.1016/j.yexmp.2015.08.003
60
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
61
Younghoon Kim, Kyoungbun Lee, Seorin Jeong, Xianyu Wen, Nam-Yun Cho, Gyeong Hoon Kang. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtypeVirchows Archiv 2019; 475(1): 49 doi: 10.1007/s00428-018-02511-7
62
Giovanni Brandi, Andrea Farioli, Annalisa Astolfi, Guido Biasco, Simona Tavolari. Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesOncotarget 2015; 6(17): 14744 doi: 10.18632/oncotarget.4539
63
Leonard M. Quinn, Nicholas Bird, Robert Jones, David Vass, Hassan Malik. Liver Cancers2019; : 199 doi: 10.1007/978-3-319-92216-4_16
64
Vincenzo Cardinale, Domenico Alvaro. PTPN3 Mutations and HBV May Exert Synergistic Effects in the Origin of the Intrahepatic CholangiocarcinomaGastroenterology 2014; 147(3): 719 doi: 10.1053/j.gastro.2014.05.046
65
Ken Nagata, Takahiro Einama, Akifumi Kimura, Michinori Murayama, Hiroteru Takeo, Makoto Nishikawa, Mayumi Hoshikawa, Takuji Noro, Sho Ogata, Suefumi Aosasa, Yoshiki Kajiwara, Eiji Shinto, Yoshihisa Yaguchi, Shuichi Hiraki, Hironori Tsujimoto, Kazuo Hase, Hideki Ueno, Junji Yamamoto. A case of intrahepatic cholangiocarcinoma that was difficult to diagnose prior to surgery: A case reportOncology Letters 2018;  doi: 10.3892/ol.2018.9666
66
Shinichi Aishima, Yoshinao Oda. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct typeJournal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 94 doi: 10.1002/jhbp.154
67
Menghua Zhou, Chaoqun Wang, Shounan Lu, Yanan Xu, Zihao Li, Hongchi Jiang, Yong Ma. Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic targetEBioMedicine 2021; 67: 103375 doi: 10.1016/j.ebiom.2021.103375
68
Hayato Nakagawa, Yuki Hayata, Tomoharu Yamada, Satoshi Kawamura, Nobumi Suzuki, Kazuhiko Koike. Peribiliary Glands as the Cellular Origin of Biliary Tract CancerInternational Journal of Molecular Sciences 2018; 19(6): 1745 doi: 10.3390/ijms19061745
69
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7
70
Jelena Djokic Kovač, Aleksandra Janković, Aleksandra Đikić-Rom, Nikica Grubor, Andrija Antić, Vladimir Dugalić. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRICurrent Oncology 2022; 29(2): 698 doi: 10.3390/curroncol29020061
71
Jinghan Wang, Linfang Li, Keqiang Zhang, Yong Yu, Bin Li, Jiang Li, Zi Yan, Zhenli Hu, Yun Yen, Mengchao Wu, Xiaoqing Jiang, Qijun Qian, Devanand Sarkar. Characterization of Two Novel Cell Lines with Distinct Heterogeneity Derived from a Single Human Bile Duct CarcinomaPLoS ONE 2013; 8(1): e54377 doi: 10.1371/journal.pone.0054377
72
Chang Hun Lee, Hong En Wang, Seung Young Seo, Seong Hun Kim, In Hee Kim, Sang Wook Kim, Soo Teik Lee, Dae Ghon Kim, Myung Kwan Han, Seung Ok Lee. Cancer related gene alterations can be detected with next-generation sequencing analysis of bile in diffusely infiltrating type cholangiocarcinomaExperimental and Molecular Pathology 2016; 101(1): 150 doi: 10.1016/j.yexmp.2016.07.010
73
Marco Casadio, Francesca Biancaniello, Diletta Overi, Rosanna Venere, Guido Carpino, Eugenio Gaudio, Domenico Alvaro, Vincenzo Cardinale. Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision MedicineInternational Journal of Molecular Sciences 2021; 22(11): 5613 doi: 10.3390/ijms22115613
74
Sunitta Saensa-ard, Saman Leuangwattanawanit, Laddawan Senggunprai, Nisana Namwat, Sarinya Kongpetch, Yaovalux Chamgramol, Watcharin Loilome, Walaiporn Khansaard, Apinya Jusakul, Auemduan Prawan, Chawalit Pairojkul, Narong Khantikeo, Puangrat Yongvanit, Veerapol Kukongviriyapan. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in ThailandTumor Biology 2017; 39(11): 101042831772592 doi: 10.1177/1010428317725925
75
Peter L. Labib, George Goodchild, Stephen P. Pereira. Molecular Pathogenesis of CholangiocarcinomaBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5391-0
76
Hamzeh Kayhanian, Elizabeth C Smyth, Chiara Braconi. Emerging molecular targets and therapy for cholangiocarcinomaWorld Journal of Gastrointestinal Oncology 2017; 9(7): 268-280 doi: 10.4251/wjgo.v9.i7.268
77
Silvestre Vicent, Ruby Lieshout, Anna Saborowski, Monique M. A. Verstegen, Chiara Raggi, Stefania Recalcati, Pietro Invernizzi, Luc J. W. van der Laan, Domenico Alvaro, Diego F. Calvisi, Vincenzo Cardinale. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaLiver International 2019; 39(S1): 79 doi: 10.1111/liv.14094
78
Alyssa M. Krasinskas. CholangiocarcinomaSurgical Pathology Clinics 2018; 11(2): 403 doi: 10.1016/j.path.2018.02.005
79
S. Di Matteo, L. Nevi, D. Costantini, D. Overi, G. Carpino, S. Safarikia, F. Giulitti, C. Napoletano, E. Manzi, A. M. De Rose, F. Melandro, M. Bragazzi, P. B. Berloco, F. Giuliante, G. Grazi, A. Giorgi, V. Cardinale, L. Adorini, E. Gaudio, D. Alvaro, Gianfranco D. Alpini. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinomaPLOS ONE 2019; 14(1): e0210077 doi: 10.1371/journal.pone.0210077
80
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological PerspectivesISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074
81
Alice Fraveto, Vincenzo Cardinale, Maria Consiglia Bragazzi, Felice Giuliante, Agostino Maria De Rose, Gian Luca Grazi, Chiara Napoletano, Rossella Semeraro, Anna Maria Lustri, Daniele Costantini, Lorenzo Nevi, Sabina Di Matteo, Anastasia Renzi, Guido Carpino, Eugenio Gaudio, Domenico Alvaro, Gianfranco Alpini. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell CulturesPLOS ONE 2015; 10(11): e0142124 doi: 10.1371/journal.pone.0142124
82
Shinichi Aishima. Pathology of the Bile Duct2017; : 149 doi: 10.1007/978-981-10-3500-5_12
83
Nieun Seo, Do Young Kim, Jin-Young Choi. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and PrognosisAmerican Journal of Roentgenology 2017; 209(2): W64 doi: 10.2214/AJR.16.16923
84
PHANTHAKARN TIT-OON, DARANEE CHOKCHAICHAMNANKIT, AMNART KHONGMANEE, PHANEE SAWANGAREETRAKUL, JISNUSON SVASTI, CHANTRAGAN SRISOMSAP. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional cultureInternational Journal of Oncology 2014; 45(5): 2108 doi: 10.3892/ijo.2014.2636
85
Annamaria Massa, Chiara Varamo, Francesca Vita, Simona Tavolari, Caterina Peraldo-Neia, Giovanni Brandi, Alessandro Rizzo, Giuliana Cavalloni, Massimo Aglietta. Evolution of the Experimental Models of CholangiocarcinomaCancers 2020; 12(8): 2308 doi: 10.3390/cancers12082308